Matt Cohen
InvestorManaging Partner at OUP (Osage University Partners) · Board director at Alphina Therapeutics
Philadelphia, Pennsylvania
Writes $5M – $10M checks · typically $7.5M
About
Matt Cohen is Managing Partner at Osage University Partners, a venture capital firm investing in innovative technologies derived from university research. He previously worked as a management consultant on projects spanning growth strategy, portfolio prioritization, commercialization planning, and commercial due diligence across multiple industries. Cohen has extensive knowledge of vaccine, immunologic, biologic, and small molecule therapeutic approaches in U.S., European, Brazilian, and Asian markets, with investments in numerous biotechnology companies including PMV Pharmaceuticals, Kura Oncology, Biohaven Pharma, Beam Therapeutics, and Sana Biotechnology.
Contact· self-published, not guessed
Board director at Alphina Therapeutics
Intro paths
In turn, Matt can intro founders to Alphina Therapeutics's investors below.
Experience
- Osage University Partners (OUP)Managing Partnercurrent2022 — presentBala-Cynwyd, Pennsylvania, United States
- Osage University Partners (OUP)Partner2019 — 2022
- Osage University Partners (OUP)Principal2016 — 2018Bala Cynwyd, Pennsylvania
- Osage University Partners (OUP)Senior Associate2013 — 2016Bala Cynwyd, Pennsylvania
- IMMvention Therapeutix, Inc.Board Membercurrent2020 — present
- L.E.K. ConsultingConsultant2011 — 2013Greater New York City Area
- L.E.K. ConsultingSenior Life Sciences Specialist2012 — 2013Greater New York City Area
- L.E.K. ConsultingLife Sciences Specialist2011 — 2012Greater New York City Area
- Penn Graduate Consulting GroupCo-President2010 — 2011University of Pennsylvania
- Penn Biotech GroupProject Manager / Life Sciences Consultant2010
Skills & more
+4 more
HealthcareOncologyDue DiligenceLife SciencesFrom Matt's professional profile.
Colleagues at OUP (Osage University Partners)
Network1
Investors connected to Matt in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Matt Cohen?
- Matt Cohen is Managing Partner at Osage University Partners, a venture capital firm investing in innovative technologies derived from university research. He previously worked as a management consultant on projects spanning growth strategy, portfolio prioritization, commercialization planning, and commercial due diligence across multiple industries. Cohen has extensive knowledge of vaccine, immunologic, biologic, and small molecule therapeutic approaches in U.S., European, Brazilian, and Asian markets, with investments in numerous biotechnology companies including PMV Pharmaceuticals, Kura Oncology, Biohaven Pharma, Beam Therapeutics, and Sana Biotechnology.
- Where does Matt Cohen work?
- Matt Cohen is Managing Partner at OUP (Osage University Partners) and Board director at Alphina Therapeutics.
- What check size does Matt Cohen write?
- Matt Cohen typically writes checks of $5M – $10M.
- Where did Matt Cohen go to school?
- Matt Cohen studied at University of Pennsylvania School of Medicine (PhD, Cell and Molecular Biology); Pennsylvania State University, Eberly College of Science (BS, Microbiology).
Same school
Also attended University of Pennsylvania School of Medicine29
+ 23 more
Shared employers
Also worked at Osage University Partners (OUP)21
+ 15 more
Also worked at IMMvention Therapeutix, Inc.4
Also worked at L.E.K. Consulting141
.jpg)
+ 135 more
